Search Results - "BIX, Gregory J"

Refine Results
  1. 1

    Roles of blood-brain barrier integrins and extracellular matrix in stroke by Edwards, Danielle N, Bix, Gregory J

    “…Ischemicstroke is a leading cause of death and disability in the United States, but recent advances in treatments [i.e., endovascular thrombectomy and tissue…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Mice deficient in endothelial α5 integrin are profoundly resistant to experimental ischemic stroke by Roberts, Jill, de Hoog, Leon, Bix, Gregory J

    “…Stroke is a disease in dire need of better therapies. We have previously shown that a fragment of the extracellular matrix proteoglycan, perlecan, has…”
    Get full text
    Journal Article
  4. 4

    The Inflammatory Response After Ischemic Stroke: Targeting β2 and β1 Integrins by Edwards, Danielle N., Bix, Gregory J.

    Published in Frontiers in neuroscience (28-05-2019)
    “…Ischemic stroke is a leading cause of death and disability with limited therapeutic options. Resulting inflammatory mechanisms after reperfusion (removal of…”
    Get full text
    Journal Article
  5. 5

    Integrin α5β1 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke by Edwards, Danielle N, Salmeron, Kathleen, Lukins, Douglas E, Trout, Amanda L, Fraser, Justin F, Bix, Gregory J

    “…Stroke remains a leading cause of death and disability with limited therapeutic options. Endothelial cell β1 integrin receptors play a direct role in…”
    Get full text
    Journal Article
  6. 6

    Bilateral carotid artery stenosis causes unexpected early changes in brain extracellular matrix and blood-brain barrier integrity in mice by Roberts, Jill M, Maniskas, Michael E, Bix, Gregory J

    Published in PloS one (12-04-2018)
    “…Bilateral carotid artery stenosis (BCAS) is one experimental model of vascular dementia thought to preferentially impact brain white matter. Indeed, few…”
    Get full text
    Journal Article
  7. 7

    Perlecan: a review of its role in neurologic and musculoskeletal disease by Lavorgna, Tessa R, Gressett, Timothy E, Chastain, Wesley H, Bix, Gregory J

    Published in Frontiers in physiology (30-05-2023)
    “…Perlecan is a 500 kDa proteoglycan residing in the extracellular matrix of endothelial basement membranes with five distinct protein domains and three heparan…”
    Get full text
    Journal Article
  8. 8

    Intra-arterial verapamil post-thrombectomy is feasible, safe, and neuroprotective in stroke by Fraser, Justin F, Maniskas, Michael, Trout, Amanda, Lukins, Doug, Parker, Lindsey, Stafford, W Lane, Alhajeri, Abdulnasser, Roberts, Jill, Bix, Gregory J

    “…Large vessel ischemic stroke represents the most disabling subtype. While t-PA and endovascular thrombectomy can recanalize the occluded vessel, good clinical…”
    Get full text
    Journal Article
  9. 9

    Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration by Hayes, Anthony J, Farrugia, Brooke L, Biose, Ifechukwude J, Bix, Gregory J, Melrose, James

    “…This review highlights the multifunctional properties of perlecan (HSPG2) and its potential roles in repair biology. Perlecan is ubiquitous, occurring in…”
    Get full text
    Journal Article
  10. 10

    Brain endothelial cell specific integrins and ischemic stroke by Guell, Kathleen, Bix, Gregory J

    Published in Expert review of neurotherapeutics (01-11-2014)
    “…Ischemic stroke, a devastating event caused by the blockage of a blood vessel(s) supplying the brain, continues to affect thousands of people in the USA every…”
    Get more information
    Journal Article
  11. 11

    Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke by Salmeron, Kathleen E, Maniskas, Michael E, Edwards, Danielle N, Wong, Raymond, Rajkovic, Ivana, Trout, Amanda, Rahman, Abir A, Hamilton, Samantha, Fraser, Justin F, Pinteaux, Emmanuel, Bix, Gregory J

    Published in Journal of neuroinflammation (14-11-2019)
    “…Stroke remains a leading cause of death and disability worldwide despite recent treatment breakthroughs. A primary event in stroke pathogenesis is the…”
    Get full text
    Journal Article
  12. 12

    Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents by Lee, Boyeon, Clarke, Douglas, Al Ahmad, Abraham, Kahle, Michael, Parham, Christi, Auckland, Lisa, Shaw, Courtney, Fidanboylu, Mehmet, Orr, Anthony Wayne, Ogunshola, Omolara, Fertala, Andrzej, Thomas, Sarah A, Bix, Gregory J

    Published in The Journal of clinical investigation (01-08-2011)
    “…Stroke is the leading cause of long-term disability and the third leading cause of death in the United States. While most research thus far has focused on…”
    Get full text
    Journal Article
  13. 13

    Co-administration of extracellular matrix-based biomaterials with neural stem cell transplantation for treatment of central nervous system injury by Damle, Eshan B, Morrison, Vivianne E, Cioma, Jozef, Volic, Milla, Bix, Gregory J

    Published in Frontiers in neuroscience (15-05-2023)
    “…Injuries and disorders of the central nervous system (CNS) present a particularly difficult challenge for modern medicine to address, given the complex nature…”
    Get full text
    Journal Article
  14. 14

    Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia by Trout, Amanda L, Rutkai, Ibolya, Biose, Ifechukwude J, Bix, Gregory J

    “…Perlecan is a heparan sulfate proteoglycan protein in the extracellular matrix that structurally and biochemically supports the cerebrovasculature by…”
    Get full text
    Journal Article
  15. 15

    Perlecan Domain V induces VEGf secretion in brain endothelial cells through integrin α5β1 and ERK-dependent signaling pathways by Clarke, Douglas N, Al Ahmad, Abraham, Lee, Boyeon, Parham, Christi, Auckland, Lisa, Fertala, Andrezj, Kahle, Michael, Shaw, Courtney S, Roberts, Jill, Bix, Gregory J

    Published in PloS one (17-09-2012)
    “…Perlecan Domain V (DV) promotes brain angiogenesis by inducing VEGF release from brain endothelial cells (BECs) following stroke. In this study, we define the…”
    Get full text
    Journal Article
  16. 16

    Recombinant Human Perlecan DV and Its LG3 Subdomain Are Neuroprotective and Acutely Functionally Restorative in Severe Experimental Ischemic Stroke by Biose, Ifechukwude Joachim, Rutkai, Ibolya, Clossen, Bryan, Gage, Gary, Schechtman, Kenneth, Adkisson, H. Davis, Bix, Gregory J.

    Published in Translational stroke research (01-12-2023)
    “…Despite recent therapeutic advancements, ischemic stroke remains a major cause of death and disability. It has been previously demonstrated that  ~ 85-kDa…”
    Get full text
    Journal Article
  17. 17

    Internal carotid artery stenosis: A novel surgical model for moyamoya syndrome by Roberts, Jill M, Maniskas, Michael E, Fraser, Justin F, Bix, Gregory J

    Published in PloS one (11-01-2018)
    “…Moyamoya is a cerebrovascular disorder characterized by progressive stenosis of the intracranial internal carotid arteries. There are two forms: Disease and…”
    Get full text
    Journal Article
  18. 18

    Intra‐arterial combination therapy for experimental acute ischemic stroke by Maniskas, Michael E., Roberts, Jill M., Gorman, Amanda, Bix, Gregory J., Fraser, Justin F.

    Published in Clinical and translational science (01-01-2022)
    “…Acute ischemic stroke continues to devastate millions of individuals worldwide. Current treatments work to restore blood flow but not rescue affected tissue…”
    Get full text
    Journal Article
  19. 19

    Perlecan Domain V Therapy for Stroke: A Beacon of Hope? by Bix, Gregory J

    Published in ACS chemical neuroscience (20-03-2013)
    “…The sad reality is that in the year 2012, people are still dying or suffering from the extreme morbidity of ischemic stroke. This tragedy is only compounded by…”
    Get full text
    Journal Article
  20. 20